Ultragenyx Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results
Published: Mar 24, 2014
NOVATO, Calif., March 24, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial results and business highlights for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.